HEPATOL INT 润色咨询

Hepatology International

出版年份：2007 年文章数：714 投稿命中率： 开通期刊会员，数据随心看

出版周期：Quarterly 自引率：3.4% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2279515, encodeId=3ce422e951550, content=这是亚太肝脏研究协会官方刊，专注成人、儿童肝胆及相关学科临床、基础研究，像原创论文、综述、诊疗指南等都收。<br>投稿时，语言得用英文，原创研究文本不超 4000 词（含参考文献），文献不超 30 条，最多6个图表。综述文本不超 5000 词，文献不超100条，至少4个彩图、4个表格 ，最多8个图表。<br>通常会邀请3位左右审稿人，初审快的话8天，整个审稿周期一般2个月左右，对文章创新性有要求。祝你投稿顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722171, createdTime=Sun Aug 31 22:28:30 CST 2025, time=2025-08-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2278371, encodeId=552d22e83713b, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：处理较快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Sat Aug 23 06:05:50 CST 2025, time=2025-08-23, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2277761, encodeId=666222e7761e7, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：几天后送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Tue Aug 19 00:58:35 CST 2025, time=2025-08-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144690, encodeId=efb9214469024, content=2周了，状态还是正在提交给杂志，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/14/adc0803ff06d9f6fc9d2bfc21391f246.jpg, createdBy=ac125183861, createdName=嘻嘻号, createdTime=Sun Jun 25 20:53:54 CST 2023, time=2023-06-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2234541, encodeId=a2e92234541fa, content=稿件需要一定的创新性，对于我这个小领域（自免肝）来说是比较难投的，课题组第3篇投中这杂志的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Fri Nov 01 11:41:40 CST 2024, time=2024-11-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2230298, encodeId=a6e722302984d, content=一般submit to journal 持续多久 ，初审时间多长，有没有投过的便宜分享经验！ 谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbf19205382, createdName=ms5000000711521518, createdTime=Fri Oct 11 10:13:20 CST 2024, time=2024-10-11, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2209329, encodeId=a6fd2209329c9, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：脂肪肝;临床<br>经验分享：感觉临床大样本数据会比较有优势，under review花了4个多月的时间，非常非常慢，但好在意见都还可以，修回后一两周就通过了，后面进展就很快了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60608443753, createdName=ms8000000674248726, createdTime=Tue Jun 11 11:30:36 CST 2024, time=2024-06-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199745, encodeId=3e782199e45f6, content=想问下大家都多久见刊的？我的接收5个月了还没见刊，但是看到同一个月接收的文章有的见刊了，有的比我晚几个月的也见刊了，发了邮件给期刊也没有回应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Mon Apr 22 09:52:21 CST 2024, time=2024-04-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2177854, encodeId=498321e785456, content=2023降区了，成3区的了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Thu Dec 28 19:56:56 CST 2023, time=2023-12-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1238700, encodeId=a0081238e00a3, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肝脏<br>经验分享：记录一下helen小硕的第一篇SCI！投稿时间是2022年4月25日；最终接受的时间是2022年8月12日。首先杂志的审稿时间还是挺快的，有3个审稿人，送审之后不到3周就开始了第一次修回（大修）；修回之后之后仅有一个审稿人提出需要有一些基础的研究（小修），给了一个月的时间，补了一些基础实验，修回之后大概等了2-3周的时间，给出了最终接受的结果。杂志整体还是比较nice，希望每个科研人文章都可以顺利接受！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94b05588321, createdName=ms6000001864840275, createdTime=Sun Aug 14 23:17:23 CST 2022, time=2022-08-14, status=1, ipAttribution=)]
    2025-08-31 ms7000002977722171 来自上海

    这是亚太肝脏研究协会官方刊，专注成人、儿童肝胆及相关学科临床、基础研究，像原创论文、综述、诊疗指南等都收。
    投稿时，语言得用英文，原创研究文本不超 4000 词（含参考文献），文献不超 30 条，最多6个图表。综述文本不超 5000 词，文献不超100条，至少4个彩图、4个表格 ，最多8个图表。
    通常会邀请3位左右审稿人，初审快的话8天，整个审稿周期一般2个月左右，对文章创新性有要求。祝你投稿顺利！

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2279515, encodeId=3ce422e951550, content=这是亚太肝脏研究协会官方刊，专注成人、儿童肝胆及相关学科临床、基础研究，像原创论文、综述、诊疗指南等都收。<br>投稿时，语言得用英文，原创研究文本不超 4000 词（含参考文献），文献不超 30 条，最多6个图表。综述文本不超 5000 词，文献不超100条，至少4个彩图、4个表格 ，最多8个图表。<br>通常会邀请3位左右审稿人，初审快的话8天，整个审稿周期一般2个月左右，对文章创新性有要求。祝你投稿顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722171, createdTime=Sun Aug 31 22:28:30 CST 2025, time=2025-08-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2278371, encodeId=552d22e83713b, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：处理较快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Sat Aug 23 06:05:50 CST 2025, time=2025-08-23, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2277761, encodeId=666222e7761e7, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：几天后送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Tue Aug 19 00:58:35 CST 2025, time=2025-08-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144690, encodeId=efb9214469024, content=2周了，状态还是正在提交给杂志，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/14/adc0803ff06d9f6fc9d2bfc21391f246.jpg, createdBy=ac125183861, createdName=嘻嘻号, createdTime=Sun Jun 25 20:53:54 CST 2023, time=2023-06-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2234541, encodeId=a2e92234541fa, content=稿件需要一定的创新性，对于我这个小领域（自免肝）来说是比较难投的，课题组第3篇投中这杂志的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Fri Nov 01 11:41:40 CST 2024, time=2024-11-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2230298, encodeId=a6e722302984d, content=一般submit to journal 持续多久 ，初审时间多长，有没有投过的便宜分享经验！ 谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbf19205382, createdName=ms5000000711521518, createdTime=Fri Oct 11 10:13:20 CST 2024, time=2024-10-11, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2209329, encodeId=a6fd2209329c9, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：脂肪肝;临床<br>经验分享：感觉临床大样本数据会比较有优势，under review花了4个多月的时间，非常非常慢，但好在意见都还可以，修回后一两周就通过了，后面进展就很快了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60608443753, createdName=ms8000000674248726, createdTime=Tue Jun 11 11:30:36 CST 2024, time=2024-06-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199745, encodeId=3e782199e45f6, content=想问下大家都多久见刊的？我的接收5个月了还没见刊，但是看到同一个月接收的文章有的见刊了，有的比我晚几个月的也见刊了，发了邮件给期刊也没有回应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Mon Apr 22 09:52:21 CST 2024, time=2024-04-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2177854, encodeId=498321e785456, content=2023降区了，成3区的了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Thu Dec 28 19:56:56 CST 2023, time=2023-12-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1238700, encodeId=a0081238e00a3, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肝脏<br>经验分享：记录一下helen小硕的第一篇SCI！投稿时间是2022年4月25日；最终接受的时间是2022年8月12日。首先杂志的审稿时间还是挺快的，有3个审稿人，送审之后不到3周就开始了第一次修回（大修）；修回之后之后仅有一个审稿人提出需要有一些基础的研究（小修），给了一个月的时间，补了一些基础实验，修回之后大概等了2-3周的时间，给出了最终接受的结果。杂志整体还是比较nice，希望每个科研人文章都可以顺利接受！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94b05588321, createdName=ms6000001864840275, createdTime=Sun Aug 14 23:17:23 CST 2022, time=2022-08-14, status=1, ipAttribution=)]
    2025-08-23 ms9000001010544398 来自福建省

    审稿速度:1.0 | 投稿命中率:75.0
    经验分享：处理较快

    4

    展开4条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2279515, encodeId=3ce422e951550, content=这是亚太肝脏研究协会官方刊，专注成人、儿童肝胆及相关学科临床、基础研究，像原创论文、综述、诊疗指南等都收。<br>投稿时，语言得用英文，原创研究文本不超 4000 词（含参考文献），文献不超 30 条，最多6个图表。综述文本不超 5000 词，文献不超100条，至少4个彩图、4个表格 ，最多8个图表。<br>通常会邀请3位左右审稿人，初审快的话8天，整个审稿周期一般2个月左右，对文章创新性有要求。祝你投稿顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722171, createdTime=Sun Aug 31 22:28:30 CST 2025, time=2025-08-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2278371, encodeId=552d22e83713b, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：处理较快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Sat Aug 23 06:05:50 CST 2025, time=2025-08-23, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2277761, encodeId=666222e7761e7, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：几天后送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Tue Aug 19 00:58:35 CST 2025, time=2025-08-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144690, encodeId=efb9214469024, content=2周了，状态还是正在提交给杂志，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/14/adc0803ff06d9f6fc9d2bfc21391f246.jpg, createdBy=ac125183861, createdName=嘻嘻号, createdTime=Sun Jun 25 20:53:54 CST 2023, time=2023-06-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2234541, encodeId=a2e92234541fa, content=稿件需要一定的创新性，对于我这个小领域（自免肝）来说是比较难投的，课题组第3篇投中这杂志的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Fri Nov 01 11:41:40 CST 2024, time=2024-11-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2230298, encodeId=a6e722302984d, content=一般submit to journal 持续多久 ，初审时间多长，有没有投过的便宜分享经验！ 谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbf19205382, createdName=ms5000000711521518, createdTime=Fri Oct 11 10:13:20 CST 2024, time=2024-10-11, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2209329, encodeId=a6fd2209329c9, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：脂肪肝;临床<br>经验分享：感觉临床大样本数据会比较有优势，under review花了4个多月的时间，非常非常慢，但好在意见都还可以，修回后一两周就通过了，后面进展就很快了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60608443753, createdName=ms8000000674248726, createdTime=Tue Jun 11 11:30:36 CST 2024, time=2024-06-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199745, encodeId=3e782199e45f6, content=想问下大家都多久见刊的？我的接收5个月了还没见刊，但是看到同一个月接收的文章有的见刊了，有的比我晚几个月的也见刊了，发了邮件给期刊也没有回应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Mon Apr 22 09:52:21 CST 2024, time=2024-04-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2177854, encodeId=498321e785456, content=2023降区了，成3区的了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Thu Dec 28 19:56:56 CST 2023, time=2023-12-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1238700, encodeId=a0081238e00a3, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肝脏<br>经验分享：记录一下helen小硕的第一篇SCI！投稿时间是2022年4月25日；最终接受的时间是2022年8月12日。首先杂志的审稿时间还是挺快的，有3个审稿人，送审之后不到3周就开始了第一次修回（大修）；修回之后之后仅有一个审稿人提出需要有一些基础的研究（小修），给了一个月的时间，补了一些基础实验，修回之后大概等了2-3周的时间，给出了最终接受的结果。杂志整体还是比较nice，希望每个科研人文章都可以顺利接受！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94b05588321, createdName=ms6000001864840275, createdTime=Sun Aug 14 23:17:23 CST 2022, time=2022-08-14, status=1, ipAttribution=)]
    2025-08-19 ms9000001010544398 来自河南省

    审稿速度:1.0 | 投稿命中率:75.0
    经验分享：几天后送审

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2279515, encodeId=3ce422e951550, content=这是亚太肝脏研究协会官方刊，专注成人、儿童肝胆及相关学科临床、基础研究，像原创论文、综述、诊疗指南等都收。<br>投稿时，语言得用英文，原创研究文本不超 4000 词（含参考文献），文献不超 30 条，最多6个图表。综述文本不超 5000 词，文献不超100条，至少4个彩图、4个表格 ，最多8个图表。<br>通常会邀请3位左右审稿人，初审快的话8天，整个审稿周期一般2个月左右，对文章创新性有要求。祝你投稿顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722171, createdTime=Sun Aug 31 22:28:30 CST 2025, time=2025-08-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2278371, encodeId=552d22e83713b, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：处理较快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Sat Aug 23 06:05:50 CST 2025, time=2025-08-23, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2277761, encodeId=666222e7761e7, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：几天后送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Tue Aug 19 00:58:35 CST 2025, time=2025-08-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144690, encodeId=efb9214469024, content=2周了，状态还是正在提交给杂志，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/14/adc0803ff06d9f6fc9d2bfc21391f246.jpg, createdBy=ac125183861, createdName=嘻嘻号, createdTime=Sun Jun 25 20:53:54 CST 2023, time=2023-06-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2234541, encodeId=a2e92234541fa, content=稿件需要一定的创新性，对于我这个小领域（自免肝）来说是比较难投的，课题组第3篇投中这杂志的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Fri Nov 01 11:41:40 CST 2024, time=2024-11-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2230298, encodeId=a6e722302984d, content=一般submit to journal 持续多久 ，初审时间多长，有没有投过的便宜分享经验！ 谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbf19205382, createdName=ms5000000711521518, createdTime=Fri Oct 11 10:13:20 CST 2024, time=2024-10-11, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2209329, encodeId=a6fd2209329c9, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：脂肪肝;临床<br>经验分享：感觉临床大样本数据会比较有优势，under review花了4个多月的时间，非常非常慢，但好在意见都还可以，修回后一两周就通过了，后面进展就很快了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60608443753, createdName=ms8000000674248726, createdTime=Tue Jun 11 11:30:36 CST 2024, time=2024-06-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199745, encodeId=3e782199e45f6, content=想问下大家都多久见刊的？我的接收5个月了还没见刊，但是看到同一个月接收的文章有的见刊了，有的比我晚几个月的也见刊了，发了邮件给期刊也没有回应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Mon Apr 22 09:52:21 CST 2024, time=2024-04-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2177854, encodeId=498321e785456, content=2023降区了，成3区的了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Thu Dec 28 19:56:56 CST 2023, time=2023-12-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1238700, encodeId=a0081238e00a3, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肝脏<br>经验分享：记录一下helen小硕的第一篇SCI！投稿时间是2022年4月25日；最终接受的时间是2022年8月12日。首先杂志的审稿时间还是挺快的，有3个审稿人，送审之后不到3周就开始了第一次修回（大修）；修回之后之后仅有一个审稿人提出需要有一些基础的研究（小修），给了一个月的时间，补了一些基础实验，修回之后大概等了2-3周的时间，给出了最终接受的结果。杂志整体还是比较nice，希望每个科研人文章都可以顺利接受！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94b05588321, createdName=ms6000001864840275, createdTime=Sun Aug 14 23:17:23 CST 2022, time=2022-08-14, status=1, ipAttribution=)]
    2023-06-25 嘻嘻号 来自江苏省

    2周了，状态还是正在提交给杂志，太慢了

    7

    展开7条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2279515, encodeId=3ce422e951550, content=这是亚太肝脏研究协会官方刊，专注成人、儿童肝胆及相关学科临床、基础研究，像原创论文、综述、诊疗指南等都收。<br>投稿时，语言得用英文，原创研究文本不超 4000 词（含参考文献），文献不超 30 条，最多6个图表。综述文本不超 5000 词，文献不超100条，至少4个彩图、4个表格 ，最多8个图表。<br>通常会邀请3位左右审稿人，初审快的话8天，整个审稿周期一般2个月左右，对文章创新性有要求。祝你投稿顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722171, createdTime=Sun Aug 31 22:28:30 CST 2025, time=2025-08-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2278371, encodeId=552d22e83713b, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：处理较快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Sat Aug 23 06:05:50 CST 2025, time=2025-08-23, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2277761, encodeId=666222e7761e7, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：几天后送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Tue Aug 19 00:58:35 CST 2025, time=2025-08-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144690, encodeId=efb9214469024, content=2周了，状态还是正在提交给杂志，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/14/adc0803ff06d9f6fc9d2bfc21391f246.jpg, createdBy=ac125183861, createdName=嘻嘻号, createdTime=Sun Jun 25 20:53:54 CST 2023, time=2023-06-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2234541, encodeId=a2e92234541fa, content=稿件需要一定的创新性，对于我这个小领域（自免肝）来说是比较难投的，课题组第3篇投中这杂志的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Fri Nov 01 11:41:40 CST 2024, time=2024-11-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2230298, encodeId=a6e722302984d, content=一般submit to journal 持续多久 ，初审时间多长，有没有投过的便宜分享经验！ 谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbf19205382, createdName=ms5000000711521518, createdTime=Fri Oct 11 10:13:20 CST 2024, time=2024-10-11, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2209329, encodeId=a6fd2209329c9, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：脂肪肝;临床<br>经验分享：感觉临床大样本数据会比较有优势，under review花了4个多月的时间，非常非常慢，但好在意见都还可以，修回后一两周就通过了，后面进展就很快了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60608443753, createdName=ms8000000674248726, createdTime=Tue Jun 11 11:30:36 CST 2024, time=2024-06-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199745, encodeId=3e782199e45f6, content=想问下大家都多久见刊的？我的接收5个月了还没见刊，但是看到同一个月接收的文章有的见刊了，有的比我晚几个月的也见刊了，发了邮件给期刊也没有回应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Mon Apr 22 09:52:21 CST 2024, time=2024-04-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2177854, encodeId=498321e785456, content=2023降区了，成3区的了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Thu Dec 28 19:56:56 CST 2023, time=2023-12-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1238700, encodeId=a0081238e00a3, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肝脏<br>经验分享：记录一下helen小硕的第一篇SCI！投稿时间是2022年4月25日；最终接受的时间是2022年8月12日。首先杂志的审稿时间还是挺快的，有3个审稿人，送审之后不到3周就开始了第一次修回（大修）；修回之后之后仅有一个审稿人提出需要有一些基础的研究（小修），给了一个月的时间，补了一些基础实验，修回之后大概等了2-3周的时间，给出了最终接受的结果。杂志整体还是比较nice，希望每个科研人文章都可以顺利接受！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94b05588321, createdName=ms6000001864840275, createdTime=Sun Aug 14 23:17:23 CST 2022, time=2022-08-14, status=1, ipAttribution=)]
    2024-11-01 ms1000001073912817 来自陕西省

    稿件需要一定的创新性，对于我这个小领域（自免肝）来说是比较难投的，课题组第3篇投中这杂志的

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2279515, encodeId=3ce422e951550, content=这是亚太肝脏研究协会官方刊，专注成人、儿童肝胆及相关学科临床、基础研究，像原创论文、综述、诊疗指南等都收。<br>投稿时，语言得用英文，原创研究文本不超 4000 词（含参考文献），文献不超 30 条，最多6个图表。综述文本不超 5000 词，文献不超100条，至少4个彩图、4个表格 ，最多8个图表。<br>通常会邀请3位左右审稿人，初审快的话8天，整个审稿周期一般2个月左右，对文章创新性有要求。祝你投稿顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722171, createdTime=Sun Aug 31 22:28:30 CST 2025, time=2025-08-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2278371, encodeId=552d22e83713b, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：处理较快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Sat Aug 23 06:05:50 CST 2025, time=2025-08-23, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2277761, encodeId=666222e7761e7, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：几天后送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Tue Aug 19 00:58:35 CST 2025, time=2025-08-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144690, encodeId=efb9214469024, content=2周了，状态还是正在提交给杂志，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/14/adc0803ff06d9f6fc9d2bfc21391f246.jpg, createdBy=ac125183861, createdName=嘻嘻号, createdTime=Sun Jun 25 20:53:54 CST 2023, time=2023-06-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2234541, encodeId=a2e92234541fa, content=稿件需要一定的创新性，对于我这个小领域（自免肝）来说是比较难投的，课题组第3篇投中这杂志的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Fri Nov 01 11:41:40 CST 2024, time=2024-11-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2230298, encodeId=a6e722302984d, content=一般submit to journal 持续多久 ，初审时间多长，有没有投过的便宜分享经验！ 谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbf19205382, createdName=ms5000000711521518, createdTime=Fri Oct 11 10:13:20 CST 2024, time=2024-10-11, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2209329, encodeId=a6fd2209329c9, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：脂肪肝;临床<br>经验分享：感觉临床大样本数据会比较有优势，under review花了4个多月的时间，非常非常慢，但好在意见都还可以，修回后一两周就通过了，后面进展就很快了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60608443753, createdName=ms8000000674248726, createdTime=Tue Jun 11 11:30:36 CST 2024, time=2024-06-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199745, encodeId=3e782199e45f6, content=想问下大家都多久见刊的？我的接收5个月了还没见刊，但是看到同一个月接收的文章有的见刊了，有的比我晚几个月的也见刊了，发了邮件给期刊也没有回应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Mon Apr 22 09:52:21 CST 2024, time=2024-04-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2177854, encodeId=498321e785456, content=2023降区了，成3区的了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Thu Dec 28 19:56:56 CST 2023, time=2023-12-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1238700, encodeId=a0081238e00a3, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肝脏<br>经验分享：记录一下helen小硕的第一篇SCI！投稿时间是2022年4月25日；最终接受的时间是2022年8月12日。首先杂志的审稿时间还是挺快的，有3个审稿人，送审之后不到3周就开始了第一次修回（大修）；修回之后之后仅有一个审稿人提出需要有一些基础的研究（小修），给了一个月的时间，补了一些基础实验，修回之后大概等了2-3周的时间，给出了最终接受的结果。杂志整体还是比较nice，希望每个科研人文章都可以顺利接受！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94b05588321, createdName=ms6000001864840275, createdTime=Sun Aug 14 23:17:23 CST 2022, time=2022-08-14, status=1, ipAttribution=)]
    2024-10-11 ms5000000711521518 来自新疆

    一般submit to journal 持续多久 ，初审时间多长，有没有投过的便宜分享经验！ 谢谢！

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2279515, encodeId=3ce422e951550, content=这是亚太肝脏研究协会官方刊，专注成人、儿童肝胆及相关学科临床、基础研究，像原创论文、综述、诊疗指南等都收。<br>投稿时，语言得用英文，原创研究文本不超 4000 词（含参考文献），文献不超 30 条，最多6个图表。综述文本不超 5000 词，文献不超100条，至少4个彩图、4个表格 ，最多8个图表。<br>通常会邀请3位左右审稿人，初审快的话8天，整个审稿周期一般2个月左右，对文章创新性有要求。祝你投稿顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722171, createdTime=Sun Aug 31 22:28:30 CST 2025, time=2025-08-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2278371, encodeId=552d22e83713b, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：处理较快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Sat Aug 23 06:05:50 CST 2025, time=2025-08-23, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2277761, encodeId=666222e7761e7, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：几天后送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Tue Aug 19 00:58:35 CST 2025, time=2025-08-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144690, encodeId=efb9214469024, content=2周了，状态还是正在提交给杂志，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/14/adc0803ff06d9f6fc9d2bfc21391f246.jpg, createdBy=ac125183861, createdName=嘻嘻号, createdTime=Sun Jun 25 20:53:54 CST 2023, time=2023-06-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2234541, encodeId=a2e92234541fa, content=稿件需要一定的创新性，对于我这个小领域（自免肝）来说是比较难投的，课题组第3篇投中这杂志的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Fri Nov 01 11:41:40 CST 2024, time=2024-11-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2230298, encodeId=a6e722302984d, content=一般submit to journal 持续多久 ，初审时间多长，有没有投过的便宜分享经验！ 谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbf19205382, createdName=ms5000000711521518, createdTime=Fri Oct 11 10:13:20 CST 2024, time=2024-10-11, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2209329, encodeId=a6fd2209329c9, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：脂肪肝;临床<br>经验分享：感觉临床大样本数据会比较有优势，under review花了4个多月的时间，非常非常慢，但好在意见都还可以，修回后一两周就通过了，后面进展就很快了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60608443753, createdName=ms8000000674248726, createdTime=Tue Jun 11 11:30:36 CST 2024, time=2024-06-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199745, encodeId=3e782199e45f6, content=想问下大家都多久见刊的？我的接收5个月了还没见刊，但是看到同一个月接收的文章有的见刊了，有的比我晚几个月的也见刊了，发了邮件给期刊也没有回应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Mon Apr 22 09:52:21 CST 2024, time=2024-04-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2177854, encodeId=498321e785456, content=2023降区了，成3区的了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Thu Dec 28 19:56:56 CST 2023, time=2023-12-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1238700, encodeId=a0081238e00a3, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肝脏<br>经验分享：记录一下helen小硕的第一篇SCI！投稿时间是2022年4月25日；最终接受的时间是2022年8月12日。首先杂志的审稿时间还是挺快的，有3个审稿人，送审之后不到3周就开始了第一次修回（大修）；修回之后之后仅有一个审稿人提出需要有一些基础的研究（小修），给了一个月的时间，补了一些基础实验，修回之后大概等了2-3周的时间，给出了最终接受的结果。杂志整体还是比较nice，希望每个科研人文章都可以顺利接受！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94b05588321, createdName=ms6000001864840275, createdTime=Sun Aug 14 23:17:23 CST 2022, time=2022-08-14, status=1, ipAttribution=)]
    2024-06-11 ms8000000674248726 来自浙江省

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向：脂肪肝;临床
    经验分享：感觉临床大样本数据会比较有优势，under review花了4个多月的时间，非常非常慢，但好在意见都还可以，修回后一两周就通过了，后面进展就很快了。

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2279515, encodeId=3ce422e951550, content=这是亚太肝脏研究协会官方刊，专注成人、儿童肝胆及相关学科临床、基础研究，像原创论文、综述、诊疗指南等都收。<br>投稿时，语言得用英文，原创研究文本不超 4000 词（含参考文献），文献不超 30 条，最多6个图表。综述文本不超 5000 词，文献不超100条，至少4个彩图、4个表格 ，最多8个图表。<br>通常会邀请3位左右审稿人，初审快的话8天，整个审稿周期一般2个月左右，对文章创新性有要求。祝你投稿顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722171, createdTime=Sun Aug 31 22:28:30 CST 2025, time=2025-08-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2278371, encodeId=552d22e83713b, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：处理较快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Sat Aug 23 06:05:50 CST 2025, time=2025-08-23, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2277761, encodeId=666222e7761e7, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：几天后送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Tue Aug 19 00:58:35 CST 2025, time=2025-08-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144690, encodeId=efb9214469024, content=2周了，状态还是正在提交给杂志，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/14/adc0803ff06d9f6fc9d2bfc21391f246.jpg, createdBy=ac125183861, createdName=嘻嘻号, createdTime=Sun Jun 25 20:53:54 CST 2023, time=2023-06-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2234541, encodeId=a2e92234541fa, content=稿件需要一定的创新性，对于我这个小领域（自免肝）来说是比较难投的，课题组第3篇投中这杂志的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Fri Nov 01 11:41:40 CST 2024, time=2024-11-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2230298, encodeId=a6e722302984d, content=一般submit to journal 持续多久 ，初审时间多长，有没有投过的便宜分享经验！ 谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbf19205382, createdName=ms5000000711521518, createdTime=Fri Oct 11 10:13:20 CST 2024, time=2024-10-11, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2209329, encodeId=a6fd2209329c9, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：脂肪肝;临床<br>经验分享：感觉临床大样本数据会比较有优势，under review花了4个多月的时间，非常非常慢，但好在意见都还可以，修回后一两周就通过了，后面进展就很快了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60608443753, createdName=ms8000000674248726, createdTime=Tue Jun 11 11:30:36 CST 2024, time=2024-06-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199745, encodeId=3e782199e45f6, content=想问下大家都多久见刊的？我的接收5个月了还没见刊，但是看到同一个月接收的文章有的见刊了，有的比我晚几个月的也见刊了，发了邮件给期刊也没有回应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Mon Apr 22 09:52:21 CST 2024, time=2024-04-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2177854, encodeId=498321e785456, content=2023降区了，成3区的了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Thu Dec 28 19:56:56 CST 2023, time=2023-12-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1238700, encodeId=a0081238e00a3, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肝脏<br>经验分享：记录一下helen小硕的第一篇SCI！投稿时间是2022年4月25日；最终接受的时间是2022年8月12日。首先杂志的审稿时间还是挺快的，有3个审稿人，送审之后不到3周就开始了第一次修回（大修）；修回之后之后仅有一个审稿人提出需要有一些基础的研究（小修），给了一个月的时间，补了一些基础实验，修回之后大概等了2-3周的时间，给出了最终接受的结果。杂志整体还是比较nice，希望每个科研人文章都可以顺利接受！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94b05588321, createdName=ms6000001864840275, createdTime=Sun Aug 14 23:17:23 CST 2022, time=2022-08-14, status=1, ipAttribution=)]
    2024-04-22 ms4000001768031770 来自广东省

    想问下大家都多久见刊的？我的接收5个月了还没见刊，但是看到同一个月接收的文章有的见刊了，有的比我晚几个月的也见刊了，发了邮件给期刊也没有回应

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2279515, encodeId=3ce422e951550, content=这是亚太肝脏研究协会官方刊，专注成人、儿童肝胆及相关学科临床、基础研究，像原创论文、综述、诊疗指南等都收。<br>投稿时，语言得用英文，原创研究文本不超 4000 词（含参考文献），文献不超 30 条，最多6个图表。综述文本不超 5000 词，文献不超100条，至少4个彩图、4个表格 ，最多8个图表。<br>通常会邀请3位左右审稿人，初审快的话8天，整个审稿周期一般2个月左右，对文章创新性有要求。祝你投稿顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722171, createdTime=Sun Aug 31 22:28:30 CST 2025, time=2025-08-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2278371, encodeId=552d22e83713b, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：处理较快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Sat Aug 23 06:05:50 CST 2025, time=2025-08-23, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2277761, encodeId=666222e7761e7, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：几天后送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Tue Aug 19 00:58:35 CST 2025, time=2025-08-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144690, encodeId=efb9214469024, content=2周了，状态还是正在提交给杂志，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/14/adc0803ff06d9f6fc9d2bfc21391f246.jpg, createdBy=ac125183861, createdName=嘻嘻号, createdTime=Sun Jun 25 20:53:54 CST 2023, time=2023-06-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2234541, encodeId=a2e92234541fa, content=稿件需要一定的创新性，对于我这个小领域（自免肝）来说是比较难投的，课题组第3篇投中这杂志的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Fri Nov 01 11:41:40 CST 2024, time=2024-11-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2230298, encodeId=a6e722302984d, content=一般submit to journal 持续多久 ，初审时间多长，有没有投过的便宜分享经验！ 谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbf19205382, createdName=ms5000000711521518, createdTime=Fri Oct 11 10:13:20 CST 2024, time=2024-10-11, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2209329, encodeId=a6fd2209329c9, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：脂肪肝;临床<br>经验分享：感觉临床大样本数据会比较有优势，under review花了4个多月的时间，非常非常慢，但好在意见都还可以，修回后一两周就通过了，后面进展就很快了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60608443753, createdName=ms8000000674248726, createdTime=Tue Jun 11 11:30:36 CST 2024, time=2024-06-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199745, encodeId=3e782199e45f6, content=想问下大家都多久见刊的？我的接收5个月了还没见刊，但是看到同一个月接收的文章有的见刊了，有的比我晚几个月的也见刊了，发了邮件给期刊也没有回应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Mon Apr 22 09:52:21 CST 2024, time=2024-04-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2177854, encodeId=498321e785456, content=2023降区了，成3区的了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Thu Dec 28 19:56:56 CST 2023, time=2023-12-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1238700, encodeId=a0081238e00a3, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肝脏<br>经验分享：记录一下helen小硕的第一篇SCI！投稿时间是2022年4月25日；最终接受的时间是2022年8月12日。首先杂志的审稿时间还是挺快的，有3个审稿人，送审之后不到3周就开始了第一次修回（大修）；修回之后之后仅有一个审稿人提出需要有一些基础的研究（小修），给了一个月的时间，补了一些基础实验，修回之后大概等了2-3周的时间，给出了最终接受的结果。杂志整体还是比较nice，希望每个科研人文章都可以顺利接受！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94b05588321, createdName=ms6000001864840275, createdTime=Sun Aug 14 23:17:23 CST 2022, time=2022-08-14, status=1, ipAttribution=)]
    2023-12-28 ms4000001768031770 来自广东省

    2023降区了，成3区的了

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2279515, encodeId=3ce422e951550, content=这是亚太肝脏研究协会官方刊，专注成人、儿童肝胆及相关学科临床、基础研究，像原创论文、综述、诊疗指南等都收。<br>投稿时，语言得用英文，原创研究文本不超 4000 词（含参考文献），文献不超 30 条，最多6个图表。综述文本不超 5000 词，文献不超100条，至少4个彩图、4个表格 ，最多8个图表。<br>通常会邀请3位左右审稿人，初审快的话8天，整个审稿周期一般2个月左右，对文章创新性有要求。祝你投稿顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722171, createdTime=Sun Aug 31 22:28:30 CST 2025, time=2025-08-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2278371, encodeId=552d22e83713b, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：处理较快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Sat Aug 23 06:05:50 CST 2025, time=2025-08-23, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2277761, encodeId=666222e7761e7, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：几天后送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Tue Aug 19 00:58:35 CST 2025, time=2025-08-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144690, encodeId=efb9214469024, content=2周了，状态还是正在提交给杂志，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/14/adc0803ff06d9f6fc9d2bfc21391f246.jpg, createdBy=ac125183861, createdName=嘻嘻号, createdTime=Sun Jun 25 20:53:54 CST 2023, time=2023-06-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2234541, encodeId=a2e92234541fa, content=稿件需要一定的创新性，对于我这个小领域（自免肝）来说是比较难投的，课题组第3篇投中这杂志的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Fri Nov 01 11:41:40 CST 2024, time=2024-11-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2230298, encodeId=a6e722302984d, content=一般submit to journal 持续多久 ，初审时间多长，有没有投过的便宜分享经验！ 谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbf19205382, createdName=ms5000000711521518, createdTime=Fri Oct 11 10:13:20 CST 2024, time=2024-10-11, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2209329, encodeId=a6fd2209329c9, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：脂肪肝;临床<br>经验分享：感觉临床大样本数据会比较有优势，under review花了4个多月的时间，非常非常慢，但好在意见都还可以，修回后一两周就通过了，后面进展就很快了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60608443753, createdName=ms8000000674248726, createdTime=Tue Jun 11 11:30:36 CST 2024, time=2024-06-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199745, encodeId=3e782199e45f6, content=想问下大家都多久见刊的？我的接收5个月了还没见刊，但是看到同一个月接收的文章有的见刊了，有的比我晚几个月的也见刊了，发了邮件给期刊也没有回应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Mon Apr 22 09:52:21 CST 2024, time=2024-04-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2177854, encodeId=498321e785456, content=2023降区了，成3区的了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Thu Dec 28 19:56:56 CST 2023, time=2023-12-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1238700, encodeId=a0081238e00a3, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肝脏<br>经验分享：记录一下helen小硕的第一篇SCI！投稿时间是2022年4月25日；最终接受的时间是2022年8月12日。首先杂志的审稿时间还是挺快的，有3个审稿人，送审之后不到3周就开始了第一次修回（大修）；修回之后之后仅有一个审稿人提出需要有一些基础的研究（小修），给了一个月的时间，补了一些基础实验，修回之后大概等了2-3周的时间，给出了最终接受的结果。杂志整体还是比较nice，希望每个科研人文章都可以顺利接受！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94b05588321, createdName=ms6000001864840275, createdTime=Sun Aug 14 23:17:23 CST 2022, time=2022-08-14, status=1, ipAttribution=)]
    2022-08-14 ms6000001864840275

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向：肝脏
    经验分享：记录一下helen小硕的第一篇SCI！投稿时间是2022年4月25日；最终接受的时间是2022年8月12日。首先杂志的审稿时间还是挺快的，有3个审稿人，送审之后不到3周就开始了第一次修回（大修）；修回之后之后仅有一个审稿人提出需要有一些基础的研究（小修），给了一个月的时间，补了一些基础实验，修回之后大概等了2-3周的时间，给出了最终接受的结果。杂志整体还是比较nice，希望每个科研人文章都可以顺利接受！

    2

    展开2条回复
共78条页码: 1/8页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分